학술논문

A Multicenter Study Evaluating the Discontinuation of Eculizumab Therapy in Children with Atypical Hemolytic Uremic Syndrome.
Document Type
Article
Source
Children; Nov2022, Vol. 9 Issue 11, p1734, 11p
Subject
THERAPEUTIC use of monoclonal antibodies
RESEARCH
STATISTICS
CONFIDENCE intervals
RETROSPECTIVE studies
FISHER exact test
DISEASE relapse
RISK assessment
DESCRIPTIVE statistics
KAPLAN-Meier estimator
HEMOLYTIC-uremic syndrome
TERMINATION of treatment
DATA analysis software
DATA analysis
DISEASE risk factors
CHILDREN
Language
ISSN
22279067
Abstract
Copyright of Children is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)